Executive Vice President

Director

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

Institution	Shares	Value	Change
Montrusco Bolton Investments	372,788	$196M	INCREASED
Comgest Global Investors S.a.S	262,562	$138M	INCREASED
Congress Asset Management	190,193	$100M	INCREASED
Assenagon Asset Management	183,233	$96M	INCREASED
Robeco Institutional Asset Management B.V	172,393	$91M	DECREASED

Insider	Type	Shares	Value	Date
George Fennell (Executive Vice President)	SELL	284	$161K	2026-06-01
George Fennell (Executive Vice President)	EXERCISE	639		2026-06-01
Irene Chang Britt (Director)	AWARD	234		2026-05-12
Irene Chang Britt (Director)	AWARD	525	$280K	2026-05-12
Bruce L. Claflin (Director)	AWARD	234		2026-05-12

Idexx Laboratories Inc (IDXX) Ownership & Trading Activity

Top Institutional Holders

Recent Insider Trades

Recent Congressional Trades